Umbilical Cord-derived Mesenchymal Stem Cell (Vinmec Research Institute of Stem Cell and Gene Technology)

N/A

Report date: 2025/03/28 14:42:51

Base Information

Drug NameUmbilical Cord-derived Mesenchymal Stem Cell (Vinmec Research Institute of Stem Cell and Gene Technology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Donor > Allogeneic
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsSexual Dysfunction, PhysiologicalBronchopulmonary DysplasiaPulmonary Disease, Chronic Obstructive +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryVietnam
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVinmec Research Institute Of Stem Cell And Gene Technology
China Registration ClassN/A

Develop Information

Active CompaniesVinmec Research Institute Of Stem Cell And Gene Technology
Inactive CompaniesN/A
Active IndicationsSexual Dysfunction, PhysiologicalPulmonary Disease, Chronic ObstructiveLiver Cirrhosis +[4] 
Inactive IndicationsBronchopulmonary Dysplasia

Other Information

ATC CodeN/A
Related LinksN/A